1 / 27

Risk in innovation: balancing benefits and hazards Case study: endocrine disruption

Risk in innovation: balancing benefits and hazards Case study: endocrine disruption. The Queen’s Medical Research Institute Medical School Main Hospital. Richard M Sharpe E-mail: r.sharpe@ed.ac.uk. Endocrine disruption and human health An up-front reality check.

archer
Télécharger la présentation

Risk in innovation: balancing benefits and hazards Case study: endocrine disruption

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Risk in innovation: balancing benefits and hazardsCase study: endocrine disruption The Queen’s Medical Research Institute Medical School Main Hospital Richard M Sharpe E-mail: r.sharpe@ed.ac.uk

  2. Endocrine disruption and human healthAn up-front reality check Endocrine disruption is responsible for a major portion of human health disorders and is certainly responsible for the changing face of human disease – so-called ‘Western diseases’ Therefore, identifying the causes and preventing them is both desirable and feasible The big issue is what is causing the endocrine disruption? Is it environmental ‘endocrine disruptors’ or is it other factors related to our modern lifestyle?

  3. Endocrine disruption is all around us

  4. Eating and drinking causes ‘endocrine disruption’

  5. Diet, hormones and getting fat Hormone effects of eating ‘high sugar’ foods So, is sugar an endocrine disruptor?

  6. Eating and drinking causes ‘endocrine disruption’ Increase in visceral (intra-abdominal) fat leads to a decrease in circulating testosterone levels (even in young men)

  7. Relationship between blood testosterone and metabolic syndrome features in adult men From: Traish et al (2011) Amer J Med 124: 578-587

  8. Endocrine disruptorsDefinition – why the concern Endocrine disruptors are exogenous substances that alter function(s) of the endocrine system and consequently cause adverse health effects in an intact organism, or its progeny, or (sub)populations Many man-made chemicals have intrinsic agonistic or antagonistic hormonal activity and may thus affect one or more hormone systems in the body. Examples are: alklyphenols, DDT, certain other pesticides, bisphenol A A Other compounds have activities that alter endogenous hormone production within the body. Examples are certain phthalates, azole compounds, bisphenol A B

  9. Cryptorchidism Hypospadias ? Subnormal T production or action The commonest reproductive disorders of the developing and young adult male‘Testicular dysgenesis syndrome (TDS)’ Testis GC cancer Low sperm counts Low testosterone

  10. An animal model for human TDS? • Gestational exposure (E13-E21) of the rat to high doses of certain phthalate esters [eg dibutyl phthalate (DBP) or diethylhexyl phthalate] results in: • Dose-dependent induction of: • Cryptorchidism • Hypospadias • Low testis weight/subfertility • Abnormalities in fetal germ cell development • Suppression of fetal testosterone and Insl3 • Reduction in anogenital distance (AGD)

  11. Exposure of pregnant rats to a plasticiser (dibutyl phthalate (DBP; 500mg/kg/day) reduces fetal testosterone Control DBP Partly from Scott et al (2008) Endocrinology 149:5820

  12. Fetal human testis xenograftinginto (castrate male) nude mice • Grafts grow normally for 6+ weeks • Treating the host with DBP is thus like experimentally exposing the real human fetal testis • Can measure testosterone production by the grafts

  13. Exposure of human fetal testis xenografts to 500mg/kg/day DBP has no steroidogenic effects Xenografts recovered + 6 weeks; hCG treatment from 1-6 weeks Data show Means ± SEM for N=8 fetuses (14-20 weeks’ gestation) Statistical analysis was by paired t test From Mitchell et al (2012) JCEM 97: E341-E348

  14. The (ongoing) bisphenol A story ‘Feeding your baby from a polycarbonate milk bottle* is like feeding it a contraceptive pill’ (Fred vomSaal) *containing bisphenol A, which has weak estrogenic activity

  15. Bisphenol A estrogenicityThe reality The reality is that you would need thousands of ‘bisphenol A pills’ to match an oral contraceptive pill for estrogenic potency

  16. So what is the ‘truth’ about bisphenol A?Is it an ‘obesogen’? • We are all exposed • Our main route (95%) of exposure is dietary (oral) • Conjugation of BPA occurs rapidly in the body rendering it biologically inactive • Most measurements of BPA in the body (including exposure) are detecting primarily conjugated BPA

  17. Effect of switching to a fresh food dietfor 3 days on Bisphenol A exposure So a ‘healthier’ fresh food diet is associated with markedly lower BPA levels. Such a diet is also clearly associated with lower risk of obesity, type 2 diabetes, cardiovascular disease etc From: Rudel et al (2011) Environ Health Perspect 119: 914

  18. This is what we suggest as a hypothesis – which requires urgent investigation RM Sharpe & AJ Drake Obesity, type 2 diabetes etc Western diet Higher bisphenol A exposure

  19. A real endocrine disruptor issue that will not go away The risk posed by exposure to ‘low level’ combinations of endocrine disruptors The ‘mixtures’ issue - ‘The cocktail effect’

  20. Effects of perinatal exposure to mixturesof ‘anti-androgenic’ chemicals in rats Data courtesy of Earl Gray (EPA, USA)

  21. ‘Real-world’ exposure to environmentalchemicals: effects on testis development • Ewes reared on pasture fertilized with: • Conventional fertiliser (= control) • Sewage sludge* (= treated) For ~20 common contaminants quantified in mothers/fetuses there was no significant increase in sludge-exposed animals *According to EU recommendations

  22. Sperm production in adulthood in sheepafter rearing on control or ‘treated’ pasture Adapted from Bellingham et al (2011) Int J Androl doi: 10.1111/j.1365-2605.2011.01234.x

  23. Another case of endocrine disruption?Thank you for your attention

More Related